This $26.5 Billion Listing Ranks Behind Only SpaceX in U.S. Market History

This is best viewed as a capital-allocation story inside a structurally tight oligopoly: the near-term beneficiary is the vendor with the most leverage to HBM mix and the least need to discount inventory, while the hidden loser is downstream AI compute hardware if memory stays the bottleneck. The key second-order effect is that capacity expansion does not automatically translate into proportional value creation; once the market believes a new fab wave is coming, forward margins can compress well before shipment growth slows, especially if Samsung and Micron respond aggressively.

The market’s biggest mistake is likely extrapolating peak scarcity into a straight-line earnings model. A 1-3 month catalyst path is limited unless we get evidence of sustained contract-price strength or tighter-than-expected HBM allocation; otherwise the stock may simply trade on sentiment and valuation rerating. Over 6-18 months, the real risk is a capex supercycle: if everyone spends simultaneously, the industry can move from shortage to oversupply faster than investors expect, which would hit multiples before it hits revenue.

Contrarian view: the cheap-looking forward multiple may just be a peak-earnings multiple wearing a growth-stock disguise. The most attractive expression is not necessarily outright long equity, but a relative-value trade against a more commodity-exposed memory name or a broad semis basket. What would falsify the bullish thesis is any sign that HBM pricing weakens, utilization normalizes faster than expected, or management starts guiding to slower margin expansion despite capacity additions.